Search Login Register

tocilizumab Summary

Description: anti-IL-6 receptor antibody for treatment of rheumatoid arthritis, Crohn's disease & Castleman disease

Also Known As: actemra

Networked: 770 relevant articles (199 outcomes, 147 trials/studies) for this Drug

Key Diseases for which tocilizumab is Relevant

  1. Rheumatoid Arthritis : 90 outcomes 93 studies in 414 results
  2. Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis) : 20 outcomes 19 studies in 73 results
  3. Giant Lymph Node Hyperplasia (Castleman's Disease) : 14 outcomes 6 studies in 35 results
  4. Amyloidosis : 11 outcomes 1 study in 26 results
  5. Arthritis (Polyarthritis) : 8 outcomes 3 studies in 25 results
Show All >>

Drugs Related to tocilizumab

  1. Interleukin-6 (Interleukin 6)
  2. Methotrexate (Mexate)
  3. Interleukin-6 Receptors (Interleukin 6 Receptor)
  4. abatacept (BELATACEPT)
  5. infliximab (Remicade)
  6. Antirheumatic Agents (DMARD)
  7. rituximab (Mabthera)
  8. TNFR-Fc fusion protein (etanercept)
  9. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  10. adalimumab (Humira)
Show All >>

Therapies Related to tocilizumab

  1. Aftercare (After-Treatment)
  2. Drug Therapy (Chemotherapy)
  3. Molecular Targeted Therapy
  4. Immunomodulation
  5. Remission Induction
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.